机构:[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China,四川大学华西医院[2]Division of Surgery and Interventional Science, University College London, London, United Kingdom,[3]Research Core Facilities, West China Hospital, Sichuan University, Chengdu, Sichuan, China,四川大学华西医院[4]Department of Pathology, Ningbo Clinical Pathology Diagnosis Center, Ningbo, Zhejiang, China
This research was funded
by Chinese Scholarship Council (grant no. 202406240158).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类|2 区医学
小类|2 区免疫学
最新[2025]版:
大类|2 区医学
小类|2 区免疫学
第一作者:
第一作者机构:[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China,[2]Division of Surgery and Interventional Science, University College London, London, United Kingdom,
共同第一作者:
通讯作者:
通讯机构:[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China,[2]Division of Surgery and Interventional Science, University College London, London, United Kingdom,
推荐引用方式(GB/T 7714):
Wu Ruicheng,Li Dengxiong,Zhang Shuxia,et al.Comprehensive pan-cancer analysis identifies PLAG1 as a key regulator of tumor immune microenvironment and prognostic biomarker[J].Frontiers In Immunology.2025,16:1572108.doi:10.3389/fimmu.2025.1572108.
APA:
Wu Ruicheng,Li Dengxiong,Zhang Shuxia,Wang Jie,Yu Qingxin...&Han Ping.(2025).Comprehensive pan-cancer analysis identifies PLAG1 as a key regulator of tumor immune microenvironment and prognostic biomarker.Frontiers In Immunology,16,
MLA:
Wu Ruicheng,et al."Comprehensive pan-cancer analysis identifies PLAG1 as a key regulator of tumor immune microenvironment and prognostic biomarker".Frontiers In Immunology 16.(2025):1572108